To the best of our knowledge, this is the first study to evaluate the intra-thoracic radiological findings of advanced-stage lung adenocarcinoma with mutations in three common oncogenes: EGFR, KRAS, and ALK. This evidence concerns the gene ALK and lung adenocarcinoma.